Oncology & Cancer

Study provides evidence for new approaches to prostate cancer

Monitoring prostate cancer (PC) by active surveillance (AS), with the expectation to initiate treatment if the cancer progresses, is a preferred initial option for men with low-risk PC and a life expectancy of at least 10 ...

Oncology & Cancer

Swedish model for PSA testing has little effect on mortality

The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk ...

Oncology & Cancer

Popular prostate cancer therapy may be harmful

A widely used treatment for prostate cancer may cause more harm than good for some patients, according to Dr. Oliver Sartor, medical director of the Tulane Cancer Center.

page 9 from 13